Akums posts strong FY26 performance as EBITDA surges 61.6% in Q4

Bayer posts strong Q1 2026 results as Crop Science surge lifts earnings & outlook

Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

We are building an AI-native operating system for pharma sales and distribution

Gilead posts solid Q1 2026 growth & raises full-year outlook on HIV momentum

Plus Therapeutics subsidiary clears key Medicare milestone

Paves way for CNS cancer test rollout

HealthQuad invests in AI-powered LifeSigns

Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets

Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum

The standout story remains Wegovy, particularly its new oral formulation

NIFTY Pharma remains resilient amid mixed market sentiment

Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures

Lilly posts explosive Q1 2026 results

Lifts full-year outlook as obesity drug boom accelerates

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine